Goldman Sachs’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.4K | Buy |
|
|||||
|
2025
Q1 | $13.1K | Sell |
|
|||||
|
2024
Q4 | $61.3K | Buy |
|
|||||
|
2024
Q3 | $90.8K | Buy |
|
|||||
|
2024
Q2 | $51K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $24K | Buy |
|
|||||
|
2022
Q1 | $17K | Sell |
|
|||||
|
2021
Q4 | $23K | Sell |
|
|||||
|
2021
Q3 | $57K | Sell |
|
|||||
|
2021
Q2 | $58K | Sell |
|
|||||
|
2021
Q1 | $45K | Sell |
|
|||||
|
2020
Q4 | $52K | Buy |
|
|||||
|
2020
Q3 | $55K | Sell |
|
|||||
|
2020
Q2 | $64K | Buy |
|
|||||
|
2020
Q1 | $33K | Sell |
|
|||||
|
2019
Q4 | $92K | Sell |
|
|||||
|
2019
Q3 | $152K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $891K | Buy |
|
|||||
|
2018
Q4 | $48K | Sell |
|
|||||
|
2018
Q3 | $96K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $42K | Sell |
|
|||||
|
2017
Q3 | $30K | Sell |
|
|||||
|
2017
Q2 | $42K | Sell |
|
|||||
|
2017
Q1 | $40K | Buy |
|
|||||
|
2016
Q4 | $15K | Buy |
|
|||||
|
2016
Q3 | $17K | Sell |
|
|||||
|
2016
Q2 | $22K | Sell |
|
|||||
|
2016
Q1 | $23K | Sell |
|
|||||
|
2015
Q4 | $39K | Sell |
|
|||||
|
2015
Q3 | $100K | Sell |
|
|||||
|
2015
Q2 | $124K | Buy |
|
|||||
|
2015
Q1 | $64K | Buy |
|
|||||
|
2014
Q4 | $49K | Buy |
|
|||||
|
2014
Q3 | $56K | Sell |
|
|||||
|
2014
Q2 | $579K | Buy |
|
|||||
|
2014
Q1 | $79K | Buy |
|